WWW.NATURE.COM
ACLY inhibition promotes tumour immunity and suppresses liver cancer
Nature, Published online: 30 July 2025; doi:10.1038/s41586-025-09297-0Using metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma mouse models, an ATP citrate lyase inhibitor reduces tumour burden and enhances efficacy of current standards of care.
0 Comentários 0 Compartilhamentos 69 Visualizações 0 Anterior